Clinical Trial Update: Evaluation Study of a Management Strategy for Gastroesophageal Reflux Disease (GERD)

View source ↗

Summary

This clinical trial update reports completion of a study evaluating a management strategy for gastroesophageal reflux disease (GERD) sponsored by AstraZeneca.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophagitis
• Gastroesophageal Reflux Disease

Snippet

Sponsor: AstraZeneca | Conditions: Reflux, Heartburn | Status: COMPLETED